Objectives: Dysregulated neuronal activity in Cortico-Striato-Thalamo-Cortical (CSTC) networks is primarily described as the pathophysiology of Tourette Syndrome (TS). New neuromodulation techniques including noninvasive transcranial Electrical Stimulation (tES) are increasingly considered among potential therapeutic options for TS.
Introduction
ourette Syndrome (TS) is defined as a childhood neurodevelopmental condition associated with dysregulation in Cortico-Basal Ganglia-Thalamo-Cortical (CBGTC) loops [1] . It is estimated that TS affects 0.77% of the population presented through various motor and vocal tics [2, 3] . People with DIC disorders including TS may show tics such as raising the eyebrows, turning the eyes, shaking their head and repeating or uttering words and phrases [4] . Fluctuation in appearance, severity and durability of sudden or repetitive tics can be observed in different people with the same syndrome [5] . Besides biological origins, environmental stress and internal psychological factors play a defining role in the course of tic disorder [6, 7] . On the other hand, comorbid disorders including Obsessive-Compulsive Disorder (OCD), learning disabilities, Attention Deficit Disorder (ADD)/ Attention Deficit Hyperactivity Disorder (ADHD), anxiety, and mood disorder are proposed as contributing factors to tic disorders [8, 9] .
To date, the medical approach to tics management includes pharmacotherapy as the first-line intervention, which might be found ineffective or intolerable in some if not many patients [10, 11] . Therefore, as with most chronic TS, patients tend to shift towards non-drug and safer strategies to treat or manage their tic symptoms. In this regard, transcranial Direct Current Stimulation (tDCS) as an alternative and noninvasive intervention in clinical applications may be considered safe and efficient in ameliorating tic symptoms. Meanwhile, evidence to support the role of tDCS to remediate TS is still insufficient [12] . The current study aimed at reporting a patient with medication refractory TS that demonstrated sustainable clinical response to a course of tDCS.
Materials and Methods

Case description
A 31-year old male presented with a long standing history of tic disorder. His first tics were observed in his early childhood. Later, his symptoms gradually aggravated and started to dramatically impact his quality of life. Throughout the course of his symptoms, tics predominantly involved his face, shoulders and stomach. He had uncontrolled repetitive movements in his face and hands, shrugging his shoulder and repeatedly uttering the same words while speaking. Over the past several years, the patient took Pimozide 20 mg qd and Haloperidol 5 mg qd, with minimsl or suboptimal response as well as notable untoward effects including extrapyramidal symptoms, hypersomnolence, and dizziness.
Baseline evaluation
Having signed the written consent, the patient underwent a 19-channel (10-20 system) Mitsar monopolar setup Quantitative Electroencephalographic (QEEG) study upon resting, eyes-open state whilst his tic events were concurrently marked on EEG tracing using the stim-tracker setup. After preprocessing the data to obtain denoised EEG using the Neuroguide software (Applied Neuroscience, Inc. Largo, FL; version 2.8.9.2016; USA), event- 
Highlights
• Ten sessions of tDCS can ameliorate some problems in Tourette syndrome.
• The number of motor and vocal tics decreased following tDCS treatment.
• Unwanted movement was still controllable after one year follow-up.
Plain Language Summary
Tourette Syndrome (TS) is defined as a childhood neurodevelopmental condition which has harmful impact on social functioning. People with TS may show various motor and vocal tics. Although medications are available for tics, patients prefer to use non-drug and safer strategies to treat or manage their tic symptoms. In this regard, transcranial Direct Current Stimulation (tDCS) may be considered safe and efficient in ameliorating tic severity.
To test the therapy protocol with tDCS, a 31-year-old man with TS was selected to receive 10 sessions (over five days) of bilateral cathodal tDCS. In a three-month period of follow-up, the number of motor and vocal tics dramatically decreased. In sum, the current study results support the use of tDCS in patients with TS who are reluctant to use traditional treatment methods or concerned about the toxic effects of the medicines. associated segments (three seconds) were extracted from the tracing and separately analyzed.
The analysis revealed an increased alpha (8-12 Hz) Current Spectral Density (CSD) in the left frontocentral area (C 3 ). Moreover, in the FFT relative power analysis, an increased relative beta (13-30 Hz) power was noted in bioccipital and left central brain regions. Meanwhile, there was an amplitude asymmetry favoring frontal brain regions for alpha and beta frequency bands. Additionally, z-score FFT coherence analysis demonstrated hyper-coherence in the left inferior-frontal brain (FC 5 ) and central brain (FCZ) regions (Figure 1 ).
Experimental protocol The tDCS procedure
The entire procedure was performed in an academic-based Neuroscience Laboratory adhering to the ethical and professional standards laid down by the Department of Neuroscience, SUMS, for applied neuroscience service provision. The patient underwent a course of dual-channel cathodal tDCS, twice a day for five consecutive days using the Neuro-Stim two-channel tES device (Medina-Teb, Tehran).
The protocol involved a 20-second ramp-up period followed by duration of 30 minutes of stimulation at 2 mA in a fixed schedule. The anodal sites were placed above the right frontopolar area (FP 2 ), while the cathodal electrodes were positioned over the left motor cortical (C 3 ) and left inferior frontal (FC 5 ) brain regions (Figure 2 ). Cathodal electrodes were placed bilaterally over pre-motor cortical areas (C 3 , FC 5 ). Anodal electrodes were placed over right frontal area (FP 2 ). A 2-mA current was applied for 30 minutes. T1  T3  T5  T7  T9   T4  T6  T8 
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Results
The patient completed five days of stimulation sessions on twice daily basis (e.g. 9:00 and 20:00). In a threemonth period of follow-up visit after 10 sessions of tDCS application, the number of motor and vocal tics dramatically decreased. The condition was both reported by the subject (through weekly visual analogue scale records) and approved by a neurologist and a clinical neuroscientist. The patient noted that he was able to control his unwanted movement after one year follow-up; while, after a year, a weak stomach tic was reported. He felt like he was being tickled from the inside while it was not reported disabling or even unpleasant. The timeline of the remediation schedules is displayed in Figure 3 .
Classically described as a chronic neuropsychiatric disorder, TS is further defined by its harmful impact on social functioning and self-image [5] . Although therapeutic pharmacological resources for tics are accessible, the information about the differential impact of cathodal and anodal tDCS intervention is scarce in the literature.
In the current study patient, a consecutive 10-session course of cathodal suppression transcranial Direct Current Stimulation (tDCS) over motor cortical and Broca's areas diminished tic severity and the symptoms disappeared after one year since the intervention. This result followed a report in 2008 in which two adult cases with TS that received cathodal tDCS over the left motor areas of the cerebral cortex revealed significant and sustainable symptom control [13] . According to this former study, the entire spectrum of tic symptoms in both patients was gradually improved by tDCS therapeutic intervention. Likewise, another case report on a 16 year-old male with vocal and motor tics, demonstrated that cathodal tDCS over the pre-Supplementary Motor Area (SMA) was associated with a significant reduction in the percentage of tic severity compared to that of the baseline [14] .
In a review and preliminary study [12] , others showed that tDCS application was an important factor in management of TS and reduction of impairment severity. In other words, some patients with tic disorder had a more rapid decline in frequency and intensity of tics over the course of treatment. Furthermore, the latter results were partly confirmed in a recently published case series which investigated the therapeutic effects of cathodal tDCS to SMA areas in three patients with tic disorder [15] . The current study results indicated that significant improvement was achieved in one out of three patients. Meanwhile, no changes were observed during cathodal stimulation in two patients. The results indicated that tDCS intervention was not sufficiently effective in ameliorating tic symptoms. The details related to tDCS efficacy in tic disorders are outlined in Table 1 .
Due to the unclear efficiency of tDCS to reduce tic symptoms, it is yet to be proven if specific stimulation parameters are taken into account. Therefore, electrode placement, electrode size, current dosage, and frequency of remediation may constitute prominent predictors for efficacy of tDCS in TS [15] . Although the reduction in tic frequency and severity were observed in the current study patient's symptoms without adverse effects, the outcome of this single case report is behind comprehensive. However, considering the long term follow-up visit, effects of pharmacotherapy, and differences in age at onset of disorder, differences in pathology and etiology may play an important role in influencing the outcomes during neuro-stimulation. Moreover, the current study resultS can motivate further studies to focus on the mentioned indicators to evaluate tDCS as a viable therapy to facilitate the functional recovery and reduce TS manifestations.
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